Doctors missing up to 64% sleep apnoea cases
The criteria doctors use to refer patients to a sleep study appear to be insufficient, missing over 60% of patients later found to have clinically relevant obstructive sleep apnoea, according to new research published in the Medical Journal of Australia.
Obstructive sleep apnoea (OSA) affects 9–38% of adults, is associated with high morbidity and mortality, and its health-related and other costs are high.
Until recently, OSA was predominantly managed by sleep specialists. Recent changes to the Medicare Benefits Schedule now allow primary care clinicians to directly refer patients for a sleep study if they have a positive result in at least two categories of the Berlin questionnaire (BQ), or an OSA-50 score of at least 5, or a score of at least 4 on the STOP-Bang questionnaire, if they also have an Epworth sleepiness score (ESS) of 8 or more.
However, according to research led by Professor Shyamali Dharmage, from the Allergy and Lung Health Unit at the University of Melbourne’s School of Population and Global Health, a significant number of OSA patients are being missed.
Dharmage and colleagues analysed data from 424 randomly selected participants in the Tasmanian Longitudinal Health Study with OSA symptoms, who completed OSA screening questionnaires and underwent type 4 sleep studies.
They found that STOP-Bang and OSA-50 correctly identified most participants with clinically relevant OSA, but with poor specificity; the specificity and sensitivity of the BQ were both low. When combined with the criterion ESS ≥8, the specificity of each questionnaire was high, but sensitivity was low. Sensitivity and specificity could be adjusted according to specific needs by varying the STOP-Bang cut-off score together with the ESS ≥8 criterion.
The researchers recommended that the “combined use of the STOP-Bang with different cut-off scores and the ESS facilitates a flexible balance between sensitivity and specificity”.
“Our STOP-Bang/ESS-based decision support tool may assist primary care physicians make objective and uniform decisions regarding OSA assessment and referral.”
SHPA and PSA have teamed up to bring 21,000 pharmacist members up to speed on recent opioid...
More than 4000 people are taking part in a groundbreaking COVID-19 vaccine trial at Perth's...
Dr Chris Perry discusses AMAQ's issues with task substitution — highlighting concerns...